美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

NeOnc Technologies Holdings

3.68

+0.02000.55%

盤後：3.740.0600+1.63%19:30 EDT

成交量：18.87萬

成交額：68.06萬

市值：1.06億

市盈率：-1.72

高：3.72

開：3.69

低：3.45

收：3.66

52周最高：12.99

52周最低：3.01

股本：2,880.54萬

流通股本：1,202.50萬

量比：0.86

換手率：1.57%

股息：- -

股息率：- -

每股收益(TTM):-2.1361

每股收益(LYR):-3.2036

淨資產收益率：--

總資產收益率：-634.99%

市淨率：-4.89

市盈率(LYR):-1.15

資料載入中...

總覽公司新聞公告

NeOnc Technologies Holdings宣佈完成1500萬美元註冊直接發行定價，納斯達克規則下按市價面向新舊機構投資者

市場快訊——美股行情動態-Sutro Biopharma、Humacyte

NeOnc股價上漲，因其實驗性腦癌療法達到了主要研究目標

NeOnc Technologies Holdings 公布鼻內給藥 Neo100 針對複發性 IDH1 突變型高級別膠質瘤的積極 2a 期頂線結果

Neonc科技公布2026年第二季度財報，並確認將於8月12日發布Neo100二期a階段關鍵數據

Neonc Technologies：FDA認定其CMC開發方案合理，但附加生產變更條件

Neonc Technologies獲阿聯酋IND批准推進Neo100，全球開發版圖擴張，靜待二期數據里程碑

Neonc Technologies擬通過私募發行最多500萬美元A系列可轉換優先股 - 美國證券交易委員會文件披露

Neonc Technologies Holdings, Inc. 董事長兼CEO斥資約30萬美元購入公司股票，並就2025年財務業績提供説明

Neonc Technologies Holdings公司——Neo100二期a階段試驗完成患者招募，中期數據預計2026年8月公布

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/NTHI/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"NTHI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NTHI\",,,,,undefined,":{"symbol":"NTHI","market":"US","secType":"STK","nameCN":"NeOnc Technologies Holdings","latestPrice":3.68,"timestamp":1789156800000,"preClose":3.66,"halted":0,"volume":188718,"hourTrading":{"tag":"盘后","latestPrice":3.74,"preClose":3.68,"latestTime":"19:30 EDT","volume":423,"amount":1556.9331,"timestamp":1789169406833,"change":0.06,"changeRate":0.016304,"amplitude":0.016304},"delay":0,"changeRate":0.005464480874316944,"floatShares":12025000,"shares":28805400,"eps":-2.136127,"marketStatus":"休市中","change":0.02,"latestTime":"09-11 16:00:00 EDT","open":3.69,"high":3.72,"low":3.45,"amount":680633.9433138,"amplitude":0.07377,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.136127,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"listingDate":1711512000000,"exchange":"NASDAQ","adjPreClose":3.66,"preHourTrading":{"tag":"盘前","latestPrice":3.58,"preClose":3.66,"latestTime":"08:56 EDT","volume":1593,"amount":5768.6236911000005,"timestamp":1789131363364,"change":-0.08,"changeRate":-0.021858,"amplitude":0.079235},"postHourTrading":{"tag":"盘后","latestPrice":3.74,"preClose":3.68,"latestTime":"19:30 EDT","volume":423,"amount":1556.9331,"timestamp":1789169406833,"change":0.06,"changeRate":0.016304,"amplitude":0.016304},"volumeRatio":0.863381038607211},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NTHI\",,,,,undefined,":{"symbol":"NTHI","floatShares":12025000,"roa":"-634.99%","roe":"--","lyrEps":-3.203615,"volumeRatio":0.863381038607211,"shares":28805400,"dividePrice":0,"high":3.72,"amplitude":0.07377,"preClose":3.66,"low":3.45,"week52Low":3.005,"pbRate":"-4.89","psRate":"2650.76","week52High":12.99,"institutionHeld":0,"latestPrice":3.68,"eps":-2.136127,"divideRate":0,"volume":188718,"delay":0,"ttmEps":-2.136127,"open":3.69,"prevYearClose":8.27,"prevWeekClose":5.03,"prevMonthClose":4.94,"prevQuarterClose":4.53,"fiveDayClose":4.79,"twentyDayClose":3.21,"sixtyDayClose":5.18},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NTHI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-10","symbol":"NTHI","fiscalQuarterEnding":"2026/06","expectedEps":-0.16,"name":null,"time":"盤前","type":"earning","dateTimestamp":1786334400000,"reportTimeType":"pre","actualEps":-0.58},{"market":"US","date":"2026-05-15","symbol":"NTHI","fiscalQuarterEnding":"2026/03","expectedEps":-0.3,"name":null,"time":"盤後","type":"earning","dateTimestamp":1778817600000,"reportTimeType":"post","actualEps":-0.38},{"market":"US","date":"2026-03-31","symbol":"NTHI","fiscalQuarterEnding":"2025/12","expectedEps":-0.37,"name":null,"time":"盤前","type":"earning","dateTimestamp":1774929600000,"reportTimeType":"pre","actualEps":-0.72},{"market":"US","date":"2025-11-14","symbol":"NTHI","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-08-18","symbol":"NTHI","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1755489600000,"reportTimeType":"","actualEps":-0.3}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NTHI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NTHI\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1779249600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NTHI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NTHI","date":"2026-09-11","current":-1.722744,"percent":0.920765,"low":-26.074295,"twenty":-4.158229,"median":-3.040027,"eighty":-2.239017,"high":-1.357276,"avg":-3.95466,"sd":3.229626,"marketCap":90975968},"quantilePoints":[{"date":"2024-03-28","current":-18.899455,"twenty":-18.899455,"median":-18.899455,"eighty":-18.899455,"marketCap":282000000},{"date":"2025-03-28","current":-18.905834,"twenty":-19.009816,"median":-18.905834,"eighty":-18.902007,"marketCap":224950380},{"date":"2025-04-04","current":-15.093157,"twenty":-20.260752,"median":-18.902645,"eighty":-16.151884,"marketCap":179585386},{"date":"2025-04-11","current":-14.179375,"twenty":-19.504518,"median":-17.739974,"eighty":-15.124667,"marketCap":168712785},{"date":"2025-04-17","current":-11.028403,"twenty":-19.044476,"median":-15.392499,"eighty":-12.855967,"marketCap":131221055},{"date":"2025-04-25","current":-9.437162,"twenty":-18.904558,"median":-14.667776,"eighty":-10.965384,"marketCap":112287731},{"date":"2025-05-02","current":-8.444606,"twenty":-18.667559,"median":-12.525115,"eighty":-9.437162,"marketCap":100477836},{"date":"2025-05-09","current":-10.398208,"twenty":-17.342951,"median":-11.028403,"eighty":-9.33318,"marketCap":123722709},{"date":"2025-05-16","current":-2.933338,"twenty":-15.682389,"median":-10.398208,"eighty":-8.444606,"marketCap":137753858},{"date":"2025-05-23","current":-2.969802,"twenty":-15.348385,"median":-9.44504,"eighty":-3.015179,"marketCap":139466268},{"date":"2025-05-30","current":-2.99006,"twenty":-15.171931,"median":-9.437162,"eighty":-2.969802,"marketCap":140417606},{"date":"2025-06-06","current":-3.034627,"twenty":-15.093157,"median":-9.311123,"eighty":-2.969802,"marketCap":142510552},{"date":"2025-06-13","current":-2.593006,"twenty":-14.242395,"median":-8.476116,"eighty":-2.937389,"marketCap":121771366},{"date":"2025-06-20","current":-1.928548,"twenty":-14.191979,"median":-7.853798,"eighty":-2.929004,"marketCap":90567453},{"date":"2025-06-27","current":-1.616577,"twenty":-12.855967,"median":-3.034627,"eighty":-2.802066,"marketCap":75916836},{"date":"2025-07-03","current":-2.362066,"twenty":-12.222621,"median":-3.010317,"eighty":-2.532985,"marketCap":110926104},{"date":"2025-07-11","current":-1.977167,"twenty":-11.425425,"median":-2.998163,"eighty":-2.362066,"marketCap":92850666},{"date":"2025-07-18","current":-1.786743,"twenty":-11.028403,"median":-2.99006,"eighty":-2.222692,"marketCap":83908082},{"date":"2025-07-25","current":-1.904238,"twenty":-10.981139,"median":-2.959854,"eighty":-1.949616,"marketCap":89425847},{"date":"2025-08-01","current":-1.98527,"twenty":-10.618776,"median":-2.937389,"eighty":-1.970684,"marketCap":93231202},{"date":"2025-08-08","current":-1.944754,"twenty":-10.133526,"median":-2.931642,"eighty":-1.939892,"marketCap":91328524},{"date":"2025-08-15","current":-2.102765,"twenty":-9.654579,"median":-2.909028,"eighty":-1.943134,"marketCap":98748967},{"date":"2025-08-22","current":-2.604584,"twenty":-9.443464,"median":-2.799635,"eighty":-1.954478,"marketCap":110548110},{"date":"2025-08-29","current":-3.15078,"twenty":-9.437162,"median":-2.795584,"eighty":-1.970684,"marketCap":133730643},{"date":"2025-09-05","current":-3.371966,"twenty":-9.437162,"median":-2.876616,"eighty":-1.980408,"marketCap":143118611},{"date":"2025-09-12","current":-4.405675,"twenty":-9.43086,"median":-2.918386,"eighty":-1.98527,"marketCap":186992991},{"date":"2025-09-19","current":-5.457439,"twenty":-9.377293,"median":-2.933338,"eighty":-1.993373,"marketCap":231633736},{"date":"2025-09-26","current":-4.681029,"twenty":-9.292217,"median":-2.939656,"eighty":-2.005528,"marketCap":198680053},{"date":"2025-10-03","current":-5.141458,"twenty":-8.961365,"median":-2.969802,"eighty":-2.008769,"marketCap":218222354},{"date":"2025-10-10","current":-5.407785,"twenty":-8.482417,"median":-2.99006,"eighty":-2.016872,"marketCap":229526233},{"date":"2025-10-17","current":-4.730683,"twenty":-8.444606,"median":-3.002214,"eighty":-2.039561,"marketCap":200787556},{"date":"2025-10-24","current":-3.769199,"twenty":-7.97196,"median":-3.022472,"eighty":-2.067922,"marketCap":159978635},{"date":"2025-10-31","current":-4.590749,"twenty":-7.105442,"median":-3.15078,"eighty":-2.071973,"marketCap":194848230},{"date":"2025-11-07","current":-4.446301,"twenty":-6.304447,"median":-3.298614,"eighty":-2.085748,"marketCap":188717312},{"date":"2025-11-14","current":-4.053582,"twenty":-5.457439,"median":-3.638293,"eighty":-2.120592,"marketCap":172048879},{"date":"2025-11-21","current":-2.32457,"twenty":-5.457439,"median":-3.482559,"eighty":-2.150574,"marketCap":113613569},{"date":"2025-11-28","current":-3.566132,"twenty":-5.449314,"median":-3.447134,"eighty":-2.162729,"marketCap":174295011},{"date":"2025-12-05","current":-3.725512,"twenty":-5.41591,"median":-3.522302,"eighty":-2.193521,"marketCap":182084733},{"date":"2025-12-12","current":-3.733481,"twenty":-5.411396,"median":-3.568124,"eighty":-2.214589,"marketCap":182474219},{"date":"2025-12-19","current":-2.797122,"twenty":-5.405979,"median":-3.570116,"eighty":-2.278603,"marketCap":136709607},{"date":"2025-12-26","current":-3.327062,"twenty":-5.398757,"median":-3.566132,"eighty":-2.301292,"marketCap":162610430},{"date":"2026-01-02","current":-3.295186,"twenty":-5.391535,"median":-3.474488,"eighty":-2.319914,"marketCap":161052485},{"date":"2026-01-09","current":-3.916768,"twenty":-5.368062,"median":-3.548202,"eighty":-2.33285,"marketCap":191432398},{"date":"2026-01-16","current":-3.466519,"twenty":-5.344589,"median":-3.566132,"eighty":-2.344813,"marketCap":169426436},{"date":"2026-01-23","current":-3.486442,"twenty":-5.296741,"median":-3.53824,"eighty":-2.348861,"marketCap":170400151},{"date":"2026-01-30","current":-3.486442,"twenty":-5.229933,"median":-3.552186,"eighty":-2.357204,"marketCap":170400151},{"date":"2026-02-06","current":-3.681683,"twenty":-5.174862,"median":-3.566132,"eighty":-2.362066,"marketCap":179942559},{"date":"2026-02-13","current":-4.169784,"twenty":-5.146875,"median":-3.570116,"eighty":-2.389761,"marketCap":203798580},{"date":"2026-02-20","current":-3.426674,"twenty":-5.12611,"median":-3.574101,"eighty":-2.410019,"marketCap":167479005},{"date":"2026-02-27","current":-4.020365,"twenty":-5.049824,"median":-3.613946,"eighty":-2.417236,"marketCap":196495717},{"date":"2026-03-06","current":-3.835101,"twenty":-4.966315,"median":-3.638073,"eighty":-2.428412,"marketCap":187440892},{"date":"2026-03-13","current":-3.660224,"twenty":-4.933814,"median":-3.653791,"eighty":-2.438178,"marketCap":178893747},{"date":"2026-03-20","current":-3.253532,"twenty":-4.851659,"median":-3.642057,"eighty":-2.502974,"marketCap":159016664},{"date":"2026-03-27","current":-2.981402,"twenty":-4.767698,"median":-3.621915,"eighty":-2.597637,"marketCap":145716276},{"date":"2026-04-02","current":-1.961459,"twenty":-4.735197,"median":-3.603287,"eighty":-2.595322,"marketCap":121897269},{"date":"2026-04-10","current":-1.961307,"twenty":-4.734294,"median":-3.574101,"eighty":-2.414974,"marketCap":121887825},{"date":"2026-04-17","current":-2.012281,"twenty":-4.720752,"median":-3.566132,"eighty":-2.352342,"marketCap":125055639},{"date":"2026-04-24","current":-1.920085,"twenty":-4.679223,"median":-3.562148,"eighty":-2.305948,"marketCap":119325998},{"date":"2026-05-01","current":-1.771769,"twenty":-4.657556,"median":-3.53824,"eighty":-2.205893,"marketCap":110108750},{"date":"2026-05-08","current":-2.630543,"twenty":-4.597971,"median":-3.502161,"eighty":-2.162729,"marketCap":163478290},{"date":"2026-05-15","current":-2.213061,"twenty":-4.588041,"median":-3.478473,"eighty":-2.19289,"marketCap":137533354},{"date":"2026-05-22","current":-3.511755,"twenty":-4.577207,"median":-3.486442,"eighty":-2.19724,"marketCap":135694649},{"date":"2026-05-29","current":-3.138303,"twenty":-4.577207,"median":-3.483777,"eighty":-2.19881,"marketCap":121264435},{"date":"2026-06-05","current":-2.990888,"twenty":-4.568179,"median":-3.474488,"eighty":-2.200003,"marketCap":115568297},{"date":"2026-06-12","current":-2.948302,"twenty":-4.559151,"median":-3.434643,"eighty":-2.209008,"marketCap":113922747},{"date":"2026-06-18","current":-3.151407,"twenty":-4.512205,"median":-3.406752,"eighty":-2.21225,"marketCap":121770758},{"date":"2026-06-26","current":-2.954853,"twenty":-4.486024,"median":-3.393823,"eighty":-2.226031,"marketCap":114175908},{"date":"2026-07-02","current":-2.922095,"twenty":-4.474288,"median":-3.367616,"eighty":-2.229383,"marketCap":112910100},{"date":"2026-07-10","current":-3.013469,"twenty":-4.460746,"median":-3.339093,"eighty":-2.231778,"marketCap":116440808},{"date":"2026-07-17","current":-2.181241,"twenty":-4.449912,"median":-3.327062,"eighty":-2.231778,"marketCap":84283436},{"date":"2026-07-24","current":-2.436279,"twenty":-4.432759,"median":-3.283232,"eighty":-2.231778,"marketCap":94138114},{"date":"2026-07-31","current":-2.342317,"twenty":-4.416509,"median":-3.25181,"eighty":-2.244708,"marketCap":90507443},{"date":"2026-08-07","current":-2.349029,"twenty":-4.389966,"median":-3.211511,"eighty":-2.26624,"marketCap":90766777},{"date":"2026-08-14","current":-1.763689,"twenty":-4.333179,"median":-3.181853,"eighty":-2.231004,"marketCap":83246101},{"date":"2026-08-21","current":-2.401422,"twenty":-4.279913,"median":-3.15078,"eighty":-2.244708,"marketCap":113347108},{"date":"2026-08-28","current":-2.42512,"twenty":-4.273416,"median":-3.115982,"eighty":-2.26624,"marketCap":114465665},{"date":"2026-09-04","current":-2.522546,"twenty":-4.230747,"median":-3.083785,"eighty":-2.27546,"marketCap":119064177},{"date":"2026-09-11","current":-1.927457,"twenty":-4.158229,"median":-3.040027,"eighty":-2.239017,"marketCap":90975968}],"updateTime":1789348146099},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NTHI\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1159616138","title":"NeOnc Technologies Holdings宣佈完成1500萬美元註冊直接發行定價，納斯達克規則下按市價面向新舊機構投資者","url":"https://stock-news.laohu8.com/highlight/detail?id=1159616138","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159616138?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 20:01","pubTimestamp":1788955294,"startTime":"0","endTime":"0","summary":"NeOnc Technologies Holdings, Inc.今日正式对外宣布，其总额达1500万美元的注册直接发行已完成定价。此次发行严格遵守纳斯达克相关规则，按照市场价格进行，认购方涵盖多位新晋及现有机构投资者。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTHI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659909279","title":"市場快訊——美股行情動態-Sutro Biopharma、Humacyte","url":"https://stock-news.laohu8.com/highlight/detail?id=2659909279","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659909279?lang=zh_tw&edition=fundamental","pubTime":"2026-08-13 00:18","pubTimestamp":1786551516,"startTime":"0","endTime":"0","summary":".N美国东部时间11:30，道琼斯工业平均指数.DJI持平于53,793.87点。标普500指数.SPX上涨0.22%，报7,745.57点；纳斯达克综合指数.IXIC上涨0.47%，报26,569.32点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL4T4491DW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHTR","CRWV","EROC","STRO","BIVI","SLXN","DFTX","GAP","TECH","OFAL","UFO","O","NBIL","OPLN","TPL","SMMT","SMWB","LITE","ANNX","CAVA","NBIX","NCMI","LOCL","NBIS","PFGC","WXM","LQDA","RSPG","LAZR","TSHA","EAT","LITX","NTHI","HUMA","HRB","SLNCF","LUMA","ALT","ABSI","SVV","TRMB","SLN","CIEN","UAMY","DPRE","FSLR","SRHR","BETA","FRNW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658972245","title":"NeOnc股價上漲，因其實驗性腦癌療法達到了主要研究目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2658972245","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658972245?lang=zh_tw&edition=fundamental","pubTime":"2026-08-12 20:15","pubTimestamp":1786536949,"startTime":"0","endTime":"0","summary":"BUZZ-NeOnc股价上涨，因其实验性脑癌疗法达到了主要研究目标8月12日-** NeOnc Technologies股价在盘前交易中上涨12.4%，至4.89美元** 这家处于临床阶段的脑癌药物开发商表示，其实验性脑癌疗法NEO100在一项针对复发性高级别胶质瘤的中期研究中达到了主要目标。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL4S4490Y3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTHI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168273292","title":"NeOnc Technologies Holdings 公布鼻內給藥 Neo100 針對複發性 IDH1 突變型高級別膠質瘤的積極 2a 期頂線結果","url":"https://stock-news.laohu8.com/highlight/detail?id=1168273292","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168273292?lang=zh_tw&edition=fundamental","pubTime":"2026-08-12 20:01","pubTimestamp":1786536077,"startTime":"0","endTime":"0","summary":"NeOnc Technologies Holdings 宣布，其针对复发性 IDH1 突变型高级别胶质瘤患者开发的鼻内给药产品 Neo100，在 2a 期临床试验中取得了积极的顶线数据。这一结果无疑为攻克这一难治性脑瘤带来了新的希望，并进一步验证了该公司在肿瘤精准治疗领域的创新实力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTHI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120133280","title":"Neonc科技公布2026年第二季度財報，並確認將於8月12日發布Neo100二期a階段關鍵數據","url":"https://stock-news.laohu8.com/highlight/detail?id=1120133280","media":"美股速递","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120133280?lang=zh_tw&edition=fundamental","pubTime":"2026-08-10 21:02","pubTimestamp":1786366978,"startTime":"0","endTime":"0","summary":"Neonc Technologies Holdings（NTHI）今日正式披露了其2026年第二季度的财务表现。与此同时，该公司还郑重确认，其备受瞩目的Neo100二期a阶段临床试验的顶线数据，定于8月12日揭晓。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NTHI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177518473","title":"Neonc Technologies：FDA認定其CMC開發方案合理，但附加生產變更條件","url":"https://stock-news.laohu8.com/highlight/detail?id=1177518473","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177518473?lang=zh_tw&edition=fundamental","pubTime":"2026-07-15 21:17","pubTimestamp":1784121457,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局在审阅Neonc Technologies Holdings的CMC开发方案后，认为其整体思路合理。然而，监管机构针对生产过程中的变更提出了附加条件，要求公司在实施相关调整时必须满足特定要求。CMC开发是药物获批上市的关键环节，涉及药品的生产工艺、质量控制和稳定性等核心方面。FDA的认可意味着公司在该领域的技术路径基本获得肯定，而附加条件则明确了后续优化生产中需遵循的监管框架。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTHI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122121747","title":"Neonc Technologies獲阿聯酋IND批准推進Neo100，全球開發版圖擴張，靜待二期數據里程碑","url":"https://stock-news.laohu8.com/highlight/detail?id=1122121747","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122121747?lang=zh_tw&edition=fundamental","pubTime":"2026-06-23 21:05","pubTimestamp":1782219921,"startTime":"0","endTime":"0","summary":"Neonc Technologies公司宣布，其候选药物Neo100已获得阿联酋（UAE）的新药临床试验（IND）批准。这一进展标志着该公司全球开发战略的进一步拓展，为即将到来的二期临床试验数据里程碑铺平了道路。随着监管绿灯的亮起，Neo100在中东地区的临床开发路径得以开启，有望加速其作为潜在疗法的全球评估进程。公司正积极筹备后续的临床工作，市场也正密切关注其后续关键数据的发布。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTHI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172142321","title":"Neonc Technologies擬通過私募發行最多500萬美元A系列可轉換優先股 - 美國證券交易委員會文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1172142321","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172142321?lang=zh_tw&edition=fundamental","pubTime":"2026-06-12 18:05","pubTimestamp":1781258739,"startTime":"0","endTime":"0","summary":"根据提交至美国证券交易委员会（SEC）的文件，Neonc Technologies Holdings计划以私募方式发行最多价值500万美元的A系列可转换优先股。\n此次融资活动旨在为公司注入新的资本，以支持其业务发展计划。可转换优先股通常为投资者提供固定股息，并赋予其在特定条件下将股份转换为普通股的权利。\n该交易的具体条款，包括转换价格、股息率及最终发行规模，将在后续的正式协议中最终确定。公司通过此类非公开融资，可更为灵活地获取发展所需资金。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTHI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188238458","title":"Neonc Technologies Holdings, Inc. 董事長兼CEO斥資約30萬美元購入公司股票，並就2025年財務業績提供説明","url":"https://stock-news.laohu8.com/highlight/detail?id=1188238458","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188238458?lang=zh_tw&edition=fundamental","pubTime":"2026-04-14 21:02","pubTimestamp":1776171739,"startTime":"0","endTime":"0","summary":"Neonc Technologies Holdings, Inc. (以下简称\"公司\")今日宣布，其董事长兼首席执行官近期已斥资约30万美元，在公开市场购入了公司股票（股票代码：NTHI）。此次内部人士的增持行为，彰显了公司核心管理层对未来发展的坚定信心。\n与此同时，公司管理层也针对近期公布的2025年财务业绩提供了进一步的背景说明和解读，旨在帮助投资者更全面地理解公司的财务状况与战略方向。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NTHI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155729765","title":"Neonc Technologies Holdings公司——Neo100二期a階段試驗完成患者招募，中期數據預計2026年8月公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1155729765","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155729765?lang=zh_tw&edition=fundamental","pubTime":"2026-04-01 21:05","pubTimestamp":1775048712,"startTime":"0","endTime":"0","summary":"Neonc Technologies Holdings公司宣布，其创新药物Neo100的二期a阶段临床试验已完成全部患者入组工作。该项研究的重要里程碑为后续数据评估奠定基础，中期研究结果预计将于2026年8月正式披露。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTHI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}]}}